These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37704060)

  • 21. Molecular cloning and biologically active production of IpaD N-terminal region.
    Hesaraki M; Saadati M; Honari H; Olad G; Heiat M; Malaei F; Ranjbar R
    Biologicals; 2013 Jul; 41(4):269-74. PubMed ID: 23731655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of Multivalent Gold Nanoparticle Vaccines Eliciting Humoral and Cellular Immunity in an
    Sanchez-Villamil JI; Tapia D; Torres AG
    mSphere; 2022 Feb; 7(1):e0093421. PubMed ID: 35044806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB.
    Ahmed B; Loos M; Vanrompay D; Cox E
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):141-5. PubMed ID: 23102992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.
    Sagi S; Konduru B; Parida M
    Int Immunopharmacol; 2020 Aug; 85():106617. PubMed ID: 32464569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral immunization with a plant-derived chimeric protein in mice: Toward the development of a multipotent edible vaccine against E. coli O157: H7 and ETEC.
    Shojaei Jeshvaghani F; Amani J; Kazemi R; Karimi Rahjerdi A; Jafari M; Abbasi S; Salmanian AH
    Immunobiology; 2019 Mar; 224(2):262-269. PubMed ID: 30579628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.
    Gu J; Liu Y; Yu S; Wang H; Wang Q; Yi Y; Zhu F; Yu XJ; Zou Q; Mao X
    Microbes Infect; 2009 Sep; 11(10-11):835-41. PubMed ID: 19427397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
    Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X
    Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.
    Heine SJ; Franco-Mahecha OL; Chen X; Choudhari S; Blackwelder WC; van Roosmalen ML; Leenhouts K; Picking WL; Pasetti MF
    Immunol Cell Biol; 2015 Aug; 93(7):641-52. PubMed ID: 25776843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology.
    Baruah N; Ahamad N; Halder P; Koley H; Katti DS
    J Nanobiotechnology; 2023 Jan; 21(1):34. PubMed ID: 36710326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of chitosan nanoparticle containing recombinant StxB antigen of EHEC and evaluation its immunogenicity in BALB/c mice.
    Almasian P; Amani J; Arani FB; Nazarian S; Kazemi R; Tabrizi NM
    Iran J Microbiol; 2018 Dec; 10(6):361-370. PubMed ID: 30873263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
    Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
    Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.
    Ahmed B; Loos M; Vanrompay D; Cox E
    Vaccine; 2014 Jun; 32(31):3909-16. PubMed ID: 24877767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.
    Heine SJ; Diaz-McNair J; Andar AU; Drachenberg CB; van de Verg L; Walker R; Picking WL; Pasetti MF
    J Immunol; 2014 Feb; 192(4):1630-40. PubMed ID: 24453241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico and in vivo approaches to recombinant multi-epitope immunogen of GroEL provides efficient cross protection against S. Typhimurium, S. flexneri, and S. dysenteriae.
    Ardestani H; Nazarian S; Hajizadeh A; Sadeghi D; Kordbacheh E
    Mol Immunol; 2022 Apr; 144():96-105. PubMed ID: 35217247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate.
    Wan CS; Zhou Y; Yu Y; Peng LJ; Zhao W; Zheng XL
    Microbiol Immunol; 2011 Apr; 55(4):247-53. PubMed ID: 21272063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice.
    Gheybi E; Asoodeh A; Amani J
    BMC Cancer; 2023 Feb; 23(1):134. PubMed ID: 36759786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.
    Martinez-Becerra FJ; Chen X; Dickenson NE; Choudhari SP; Harrison K; Clements JD; Picking WD; Van De Verg LL; Walker RI; Picking WL
    Infect Immun; 2013 Dec; 81(12):4470-7. PubMed ID: 24060976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System.
    Umthong S; Buaklin A; Jacquet A; Sangjun N; Kerdkaew R; Patarakul K; Palaga T
    J Microbiol Biotechnol; 2015 Apr; 25(4):526-36. PubMed ID: 25348693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico design and in vivo evaluation of two multi-epitope vaccines containing build-in adjuvant with chitosan nanoparticles against uropathogenic Escherichia coli.
    Rezaei M; Esmaeili F; Reza Asadi Karam M; Ehsani P; Abbasnezhad Farsangi Z; Bouzari S
    Int Immunopharmacol; 2023 Apr; 117():109999. PubMed ID: 37012877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.